Skip to Main Content

Good morning. Elizabeth Cooney here, channeling the vacationing Ed Silverman’s Wednesday wisdom: We’ve made it this far (I think he means through the week), so why not carry on? Some news to start us off:

The U.S. will pay $1.95 billion for Pfizer (PFE) and BioNTech (BNTX) to produce and deliver 100 million doses of their jointly developed Covid-19 vaccine candidate in the U.S. if it proves safe and effective in humans, CNBC informs us. Under the agreement, the U.S. can acquire an additional 500 million doses, the Department of Health and Human Services said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!